Management of the ocular manifestations of antiphospholipid syndrome
This literature review details the diagnosis of antiphospholipid syndrome (APS) and management of its ocular manifestations. Source: AAO
- Posted on: Jun 28 2021
- Leave a response
This literature review details the diagnosis of antiphospholipid syndrome (APS) and management of its ocular manifestations. Source: AAO
Investigators assessed the safety of an on-call system serviced by junior residents that triaged patients who presented with symptoms suspicious for posterior vitreous detachment (PVD), retinal tear or retinal detachment. Source: AAO
This study evaluates the associations between tuberculosis (TB) infection and risk of Behçet disease. Source: AAO
This retrospective cohort analysis examined the impact of race and ethnicity on the efficacy of intravitreal bevacizumab for diabetic macular edema (DME). Source: AAO
This study compared the severity of chronic ocular complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) triggered by lamotrigine (LT) and trimethoprim-sulfamethoxazole (TS). Source: AAO
Investigators evaluated the efficacy of intravitreous aflibercept injections in mitigating complications in eyes with moderate to severe nonproliferative diabetic retinopathy (NPDR). Source: AAO
This study assessed the diagnostic error of neuro-ophthalmic conditions by referring providers and how it impacts patients. Source: AAO
The authors report outcomes of secondary IOL implantation in the Infant Aphakia Treatment Study (IATS). Source: AAO
This prospective, longitudinal study assessed the association between cardiovascular disease and glaucoma. Source: AAO
This IRIS Registry study assessed use of bevacizumab among patients with Medicare fee-for-service health insurance between 2013 and 2019. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »